Evolve Global Healthcare Enhanced Yield Fund (TSX: LIFE)

This ETF offers exposure to a diversified group of global drug firms.

This passively managed ETF holds 20 global healthcare companies that are the constituents of the Solactive Global Healthcare 20 Index. It has hedged and unhedged options and uses a covered call strategy for up to a third of the holdings to enhance yield.


Income Investor

Healthcare stocks underperformed the broader market in 2024 as investors favored high-growth sectors like technology and communications. More weakness came in November as investors wondered what a Trump administration would mean for drug pricing and subsidies for health insurance and vaccine programs. Robert F. Kennedy Jr., a prominent anti-vaccine activist, has been chosen to lead the Department of Health and Human Services, which is giving investors pause. These short-term challenges do not change the view that this ETF has financial depth and the experience to navigate complex regulatory demands. - Adam Mayers

Sorry!

Only current subscribers of The Income Investor may view the details of this recommendation.


Interactive Performance Chart

LIFE was first recommended here on August 17, 2024